596 related articles for article (PubMed ID: 38347575)
1. Unveiling the mechanisms and challenges of cancer drug resistance.
Khan SU; Fatima K; Aisha S; Malik F
Cell Commun Signal; 2024 Feb; 22(1):109. PubMed ID: 38347575
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanism of Resistance to Chemotherapy in Gastric Cancers, the Role of Autophagy.
Spirina LV; Avgustinovich AV; Afanas'ev SG; Cheremisina OV; Volkov MY; Choynzonov EL; Gorbunov AK; Usynin EA
Curr Drug Targets; 2020; 21(7):713-721. PubMed ID: 31775598
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Epigenetic Modulation of Drug Resistance in Cancer: Challenges and Opportunities.
Shah K; Rawal RM
Curr Drug Metab; 2019; 20(14):1114-1131. PubMed ID: 31902353
[TBL] [Abstract][Full Text] [Related]
4. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
5. Mapping the Pathways of Resistance to Targeted Therapies.
Wood KC
Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of acquired resistance to targeted cancer therapies.
Lackner MR; Wilson TR; Settleman J
Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
[TBL] [Abstract][Full Text] [Related]
7. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy.
Ye J; Wu J; Liu B
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188866. PubMed ID: 36842765
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling.
Alaoui-Jamali MA; Dupré I; Qiang H
Drug Resist Updat; 2004; 7(4-5):245-55. PubMed ID: 15533762
[TBL] [Abstract][Full Text] [Related]
10. The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
[TBL] [Abstract][Full Text] [Related]
11. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
12. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
13. Targeting epigenetic regulatory machinery to overcome cancer therapy resistance.
Guo L; Lee YT; Zhou Y; Huang Y
Semin Cancer Biol; 2022 Aug; 83():487-502. PubMed ID: 33421619
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular paradigms of multidrug resistance in cancer.
Vaidya FU; Sufiyan Chhipa A; Mishra V; Gupta VK; Rawat SG; Kumar A; Pathak C
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1291. PubMed ID: 33052041
[TBL] [Abstract][Full Text] [Related]
15. Polytherapy and Targeted Cancer Drug Resistance.
Chatterjee N; Bivona TG
Trends Cancer; 2019 Mar; 5(3):170-182. PubMed ID: 30898264
[TBL] [Abstract][Full Text] [Related]
16. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
Sui X; Chen R; Wang Z; Huang Z; Kong N; Zhang M; Han W; Lou F; Yang J; Zhang Q; Wang X; He C; Pan H
Cell Death Dis; 2013 Oct; 4(10):e838. PubMed ID: 24113172
[TBL] [Abstract][Full Text] [Related]
17. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
Wu Q; Yang Z; Nie Y; Shi Y; Fan D
Cancer Lett; 2014 Jun; 347(2):159-66. PubMed ID: 24657660
[TBL] [Abstract][Full Text] [Related]
18. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
19. Novel nanomedicines to overcome cancer multidrug resistance.
Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
[TBL] [Abstract][Full Text] [Related]
20. The emergence of drug resistance to targeted cancer therapies: Clinical evidence.
Sarmento-Ribeiro AB; Scorilas A; Gonçalves AC; Efferth T; Trougakos IP
Drug Resist Updat; 2019 Dec; 47():100646. PubMed ID: 31733611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
